| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Hepatitis A virus cellular receptor 1|HAVcr-1|Kidney injury molecule 1|KIM-1|T-cell immunoglobulin and mucin domain-containing protein 1|TIMD-1|T-cell immunoglobulin mucin receptor 1|TIM, TIM-1|T-cell membrane protein 1|HAVCR1|KIM1|TIM1|TIMD1 |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human KIM-1 (Kidney Injury Molecule 1) is a molecular target commonly studied in immunology research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of KIM-1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of KIM-1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
KIM-1 (Kidney Injury Molecule 1) may also be referenced as Hepatitis A virus cellular receptor 1, HAVcr-1, and Kidney injury molecule 1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how KIM-1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology research.
- Interpreting shifts in KIM-1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
KIM-1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Brain-derived extracellular vesicles circUsp32 polarized macrophages causing acute kidney injury after traumatic brain injury
IF: 11.7 Journal: Science Advances Author: Huanhu Hospital Affiliated to Tianjin Medical University, Tianjin Medical University, Tianjin 300070, China. Cited Date: 2025-12-05
A multiplexed UPLC-MS/MS assay for simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis
IF: 3.906 Journal: Toxicology and Applied Pharmacology Cited Date: 2019-01-15
Kidney Injury Molecule-1 as Novel Marker of the Early Subclinical Kidney Injury in Children With Type 1 Diabetes Mellitus
IF: 1.3 Journal: Sage Open Pediatrics Author: Bogomolets National Medical University, Kyiv, Ukraine. Cited Date: 2025-12-26
Altered inflammatory cytokines and mcp-1 chemokine in patients with chronic renal failure
IF: Journal: Labyrinth: Fayoum Journal of Science and Interdisciplinary Studies Author: Zoology Department, Faculty of Science, Fayoum University, El Fayoum 63514, Egypt. Cited Date: 2025-10-11
Role of Urinary Beta 2 Microglobulin and Kidney Injury Molecule-1 in Predicting Kidney Function at One Year Following Acute Kidney Injury
IF: Journal: International Journal of Nephrology and Renovascular Disease Cited Date: 2021-07-09